SCHEMBL881445

SCHEMBL881445

OCC1CCCC(Br)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18269809 0.84 — —
SCHEMBL27410255 0.82 ESR1 (0.38) —
SCHEMBL63504 0.81 ESR1 (0.39) —
SCHEMBL674423 0.81 ESR1 (0.39) —
SCHEMBL44806 0.81 ESR1 (0.39) —
SCHEMBL674422 0.81 ESR1 (0.39) —
SCHEMBL19916024 0.80 ESR1 (0.41) —
SCHEMBL27687217 0.77 — —
SCHEMBL1895624 0.76 ESR2 (0.45) —
SCHEMBL25337489 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011143669-A2 COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA, INFLAMMATORY DISEASE AND OTHER DISORDERS DANA-FARBER CANCER INSTITUTE, INC (US) 2011-11-17 — — WO disclosed
Send feedback